DANDRIT BIOTECH AS has a total of 29 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are GENCELL SA, ATUGEN AG and TRANSIMMUNE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | Australia | 3 | |
#5 | China | 2 | |
#6 | Israel | 2 | |
#7 | Norway | 2 | |
#8 | Brazil | 1 | |
#9 | Canada | 1 | |
#10 | EAPO (Eurasian Patent Organization) | 1 | |
#11 | Hong Kong | 1 | |
#12 | Malaysia | 1 | |
#13 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Zeuthen Jesper | 16 |
#2 | Kirkin Alexei | 16 |
#3 | Djandjougazian Karine | 15 |
#4 | Wakatsuki Pedersen Ayako | 8 |
#5 | Zocca Mai-Britt | 7 |
#6 | Skjoede Jensen Simon | 4 |
#7 | Holmstroem Kim | 4 |
#8 | Alexei Kirkin | 3 |
#9 | Jesper Zeuthen | 3 |
#10 | Karine Djandjougazian | 3 |
Publication | Filing date | Title |
---|---|---|
AU2013203315A1 | Method for generating dendritic cells employing decreased temperature | |
WO2009062503A1 | Micro rnas as markers of the functional state of a dendritic cell | |
WO2009062502A1 | Method for generating tolerogenic dendritic cells employing decreased temperature | |
EA015266B1 | Method for generating mature dendritic cells for inducing an immune response and use said cells | |
AU2002365291A1 | Pharmaceutical composition for inducing an immune response in a human or animal | |
CN1723038A | Induce the pharmaceutical composition of human or animal's immunne response |